|
Volumn 23, Issue 3, 2002, Pages 265-271
|
Innovations in pancreas transplantation
|
Author keywords
Pancreas after kidney transplantation; Pancreas transplantation; Pancreas transplantation alone; Simultaneous pancreas and kidney transplantation
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
GLUCOSE;
INSULIN;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
LYMPHOCYTE ANTIBODY;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
POLYCLONAL ANTIBODY;
STEROID;
TACROLIMUS;
ARTICLE;
CONTROLLED STUDY;
DIABETIC NEPHROPATHY;
DIABETIC NEUROPATHY;
DIABETIC RETINOPATHY;
DONOR;
GLUCOSE METABOLISM;
GRAFT FAILURE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HORMONE SUBSTITUTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INSULIN DEPENDENT DIABETES MELLITUS;
KIDNEY FAILURE;
KIDNEY TRANSPLANTATION;
MEDICAL DECISION MAKING;
PANCREAS TRANSPLANTATION;
PATIENT MONITORING;
PATIENT SELECTION;
POSTOPERATIVE CARE;
POSTOPERATIVE COMPLICATION;
PREOPERATIVE CARE;
PREOPERATIVE EVALUATION;
SURGICAL TECHNIQUE;
SURVIVAL RATE;
TREATMENT INDICATION;
TREATMENT OUTCOME;
DIABETES MELLITUS, TYPE 1;
HUMANS;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
PANCREAS TRANSPLANTATION;
PATIENT SELECTION;
PERIOPERATIVE CARE;
TISSUE DONORS;
|
EID: 0036213546
PISSN: 03795284
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (35)
|